Zucara Therapeutics

www.zucara.ca
1300-661 University Avenue
Toronto, ON M5G 0B7

Company Info

Year Established
2014

Contacts

Michael Midmer, MSc, MBA
CEO

Richard Liggins, PhD
CSO

Susan Peers, PhD
Director, Clinical and Regulatory Affairs

Michael Riddell, PhD
Chair

Company Description

Zucara Therapeutics is developing the first once-daily therapeutic to prevent hypoglycemia (low blood sugar) in people with diabetes.

Transfection Has Never Been So Easy With Avalanche® Transfection Reagents for Cancer Cells, Primary Cells, And Other Difficult-To-Transfect Cells.Primary Cells, And Other Difficult-To-Transfect Cells.